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CASE REPORT
Fig. 1. An erythematous well-defined and papillomatous plaque
with superficial erosion and crust on the left side of the lower
back.
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Syringocystadenoma papilliferum (SCAP) and tubular 
apocrine adenoma (TAA) are rare benign sweat gland 
tumors. SCAP and TAA may have a histopathologic overlap, 
but few cases of a SCAP combined with a TAA have been 
reported. Herein we describe an unusual case of a SCAP 
co-existing with a TAA located on the back of a 12-year-old 
girl. (Ann Dermatol 23(S2) S151∼S154, 2011)
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INTRODUCTION
Syringocystadenoma papilliferum (SCAP) and tubular 
apocrine adenoma (TAA) are rare, benign, sweat gland 
tumors. In some cases, TAAs can arise in association with 
SCAPs, and SCAPs are often situated in the superficial 
portion of TAAs
1-11. In a few cases of TAAs associated with 
SCAPs, pre-existing sebaceous nevi have been des-
cribed
1-6,8,9. Herein, we describe an unusual case of a 
SCAP accompanied by a TAA without a sebaceous nevus 
on the back of a 12-year-old girl.
CASE REPORT
A 12-year-old girl presented with multiple confluent 
erythematous papules forming a eroded plaque on the left 
lower back that had been present since birth. The lesion 
slowly enlarged with time. The patient had no other 
significant skin lesions, and the medical and family 
histories were unremarkable. On cutaneous examination, 
a 1.8×2.5 cm, well-defined, erythematous eroded plaque 
was situated on the left side of the lower back with a 
papillomatous surface and a rubbery consistency (Fig. 1). 
An excisional biopsy was performed (Fig. 2A). On the 
histopathologic examination, the overlying epidermis 
showed hyperkeratosis, acanthosis, and papillomatosis. 
The upper part of the lesion showed cystic and irregularly 
dilated tubular structures with deep invaginations, from 
which emerged thick papillomatous projections lined with 
two rows of epithelial cells. The luminal raw of cells HJ Lee, et al
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Fig. 2. Views of the tumor. (A) The upper portion of the tumor had a cystic invagination that extends downward from the epidermis,
and the lower portion exhibited islands of irregular-shaped tubular structures in the deep dermis at the excision specimen (H&E,
×20). (B) Two different epithelial cell layers lining the invaginated area and papillary projections in the upper portion of tumor. 
The luminal row consisted of high columnar cells showing active decapitation secretion, and the outer row consisted of small cuboidal
cells. There was stromal infiltration of many plasma cells (H&E, ×400). (C) The numerous cystic and branching tubular structures 
in the dermis surrounded by a paucicellular fibrous stroma. The tubular structures have a dual or multilayered epithelium and the 
luminal cells showing evidence of active decapitation secretion in the dermis (H&E, ×100).
consisted of columnar cells with oval nuclei and faintly 
eosinophilic cytoplasm. The outer row of cells consisted 
of small cuboidal cells with round nuclei and scanty 
cytoplasm. Plasma cells infiltrated the stroma (Fig. 2B). 
The deeper part of the specimen exhibited tubular 
structures of variable sizes. The numerous cystic and 
branching tubular structures in the dermis were sur-
rounded by a paucicellular fibrous stroma. The peripheral 
layer of tubular structures consisted of flattened cuboidal 
cells, and the luminar layer was composed of cuboidal 
cells. Irregular-shaped tubules have a dual or multilayered 
epithelium with the peripheral layer representing myoe-
pithelial cells. The cells lining the lumina showed 
evidence of active decapitation secretion (Fig. 2C). After 
total excision, no recurrence was noted in the following 4 
months.
DISCUSSION
A SCAP is an uncommon benign sweat gland tumor that is 
usually first noted at birth or in early childhood and 
presents as a solitary papule, several papules in a linear 
arrangement, or as a plaque. The lesion increases in size 
at puberty, becoming papillomatous and often crusted. A 
SCAP occurs most commonly on the scalp and face, but in 
25% of the cases, it occurs elsewhere (e.g., trunk, upper 
arms, vulva, and thighs)
12. Histopathologically, a SCAP 
consists of a cystic and papillary growth of epithelial 
elements projecting downward into the dermis and 
opening onto the skin surface through one or more 
orifices. Usually the tumor consists of two layers of 
epithelial cells: the peripheral layer is cuboidal and the 
inner, columnar cell layer shows evidence of decapitation Syringocystadenoma Papilliferum of the Back Combined with a Tubular Apocrine Adenoma
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Table 1. Review of the cases of SCAP combined with TAA
Reference Age/Sex Location Clinical features Size Nevus sebaceous
Toribio et al. (1987)
3 33/M Scalp An exudative, round, pediculated lesion  2 cm Unmentioned
Ansai et al. (1989)
4 22/M Scalp A pedunculated tumor with lobulated  1.3×1.6×1 cm Unmentioned
 and erosive surface
Epstein et al. (1990)
5 15/M Chest Linear grouped shiny erythematous papules  5×1 cm Unmentioned
Ishiko et al. (1993)
6 75/M Scalp A verrucous tumor located on the depigmented  1.1 cm Present
 plaque
Aktepe et al. (2003)
7 19/M Scalp A pinkish, hairless and verrucous plaque  3×1 cm Present
Ahn et al. (2004)
8 52/M Scalp A dome-shaped nodule  1.5 cm Present
Lee et al. (2005)
9 74/F External An indurated tumor with central ulceration 1.5×1 cm Absent
 auditory canal
Yamane et al. (2007)
10 77/F Breast Linearly arranged plaques, an ulcerated  10×4 cm Present
 intracutaneous nodule and a red pedunculated
 nodule forming gently curved lesion
Vazmitel et al. (2008)
11 61/M Scalp An ulcerated plaque Unmentioned Present
Kim et al. (2010)
12 40/F Scalp A pedunculated nodule 2.5 cm Present
Present case (2010) 12/F Lower back An erosive and crusted papillomatous plaque 1.8×2.5 cm Absent
SCAP: syringocystadenoma papilliferum, TAA: tubular apocrine adenoma, M: male, F: female.
secretion. The connective tissue stroma of the 
papillomatous projections is marked by rich infiltration of 
inflammatory cells; most notably there is a large number 
of plasma cells
12,13. The origin of the SCAP from either 
eccrine or apocrine structures has been supported in the 
literature. It is probable that SCAP arises from undiffe-
rentiated cells with the potential to exhibit both apocrine 
and eccrine modes of epithelial secretion. Most lesions of 
SCAP appear to be nearly of apocrine origin, but some 
exhibit eccrine derivation
13.
A TAA is also an uncommon sweat gland tumor. TAAs are 
usually found in middle-aged adults as solitary nodules 
situated mostly on the scalp. TAAs have numerous, 
irregular-shaped tubular structures that are usually lined 
by two layers of epithelial cells. The peripheral layer 
consists of cuboidal or flattened cells, and the luminal 
layer is composed of columnar cells
13. The tubules are 
embedded in a paucicellular fibrous stroma
11-13. In our 
case, the superficial portion of the tumor showed typical 
SCAP characteristics and the lower portion was repre-
sentative of a TAA. 
The association of TAAs with SCAPs was first described by 
Toribio et al.
3 in 1987. Another nine cases of SCAPs 
combined with TAAs have been reported in the English 
literature
2-10 (Table 1). In these cases, SCAPs were also 
overlaid on TAAs, as in our case. The lesions of SCAPs 
vary in morphologic character from smooth and flat to 
raised and verrucous. They also may present as solitary 
nodules or plaques, or multiple linear papules
14,15. Ten 
cases of SCAPs combined with TAAs showed a wide 
variety of surface appearances; the various morphologic 
characteristics could be associated with a superficial 
portion of the SCAP. 
SCAPs have been found in 8∼19% of the lesions of 
sebaceous nevi, and are one of the most commonly 
associated appendage tumors of sebaceous nevi
13. Six of 
10 cases of TAAs associated with SCAPs showed 
pre-existing sebaceous nevi
1-6. Three of 10 cases did not 
mention sebaceous nevi
8-10. In the 3 cases, there might 
have been no evidence of sebaceous nevi. Only one case 
of a TAA with a SCAP in the external auditory canal has 
been reported with no background of sebaceous nevi
9. In 
our case, the lower portion of the lesion with a tubular 
structure may have been ectopic apocrine glands in an 
underdeveloped sebaceous nevus because our patient was 
pre-pubertal. Nevertheless, we concluded that our case 
was a SCAP combined with a TAA because there was no 
evidence of a pre-existing sebaceous nevus in the 
completely excised specimen. The intradermal tubular 
component may be a part of SCAP
16. However, the 
tubular structures in our case were numerous and 
consisted of compactly gathered forming islands, and so 
were characteristic of TAA. Also, our case presented on 
the back, which is a rare site for a sebaceous nevus to 
develop
17. The present case is the first report of a SCAP 
accompanied with a TAA on the back without a 
sebaceous nevus before puberty. 
TAAs and SCAPs may exhibit histopathologic overlap. 
Kazakov et al.
13 conducted an interobserver study for a 
histopathologic reappraisal of tubular adenomas (TAs) and 
SCAPs with four dermatopathologists. The study con-
firmed a morphologic overlap between TAs and SCAPs HJ Lee, et al
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and demonstrated a lack of universally accepted 
diagnostic criteria to classify the lesions with morphologic 
overlap between TAs and SCAPs, even among experien-
ced dermatopathologists and pathologists. 
Ishiko et al.
6 reviewed 19 cases of TAAs described in the 
literature. In 10 of the 19 TAA cases, the tumor was 
connected to the overlying epidermis and it was necessary 
to differentiate the lesion from a SCAP. They described 
TAAs as being different from SCAPs in several aspects: 1) 
TAAs show no cystically-dilated apocrine invaginations 
extending down from the epidermis; 2) papillary projec-
tions are absent; and 3) infiltration of plasma cells is rare 
or absent. 
The term tubulopapillary hidradenoma (TPH) was first 
proposed by Falck and Jordaan
18 in 1986, and is a 
recently proposed category of adnexal tumors that remains 
controversial. A TPH encompasses a spectrum of lesions 
from papillary eccrine adenomas (PEAs) to TAAs. This 
designation indicates a variable degree of differentiation 
from both apocrine and eccrine glands and it is difficult to 
precisely distinguish between these types of tumors. A 
TPH is also closely related to a SCAP. Even though this 
classification is controversial, it has been proposed that 
PEAs, TAAs, and SCAPs are an inter-related group of 
appendage tumors
13,19. Recent studies have suggested that 
these tumors arise from either pleuripotential appendage 
cells or apo-eccrine glands
5.
In summary, we present a case of a SCAP on the lower 
back that was histopathologically associated with a TAA 
without a sebaceous nevus. Despite the rare occurrence, 
this entity can be considered when similar skin lesions are 
observed.
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